Brain Tumor Center
The Brain Tumor Center boasts a coherent multi-disciplinary care system. We have specialists and nurse practitioners from radiology, pathology, radiation oncology, hemato-oncology, otolaryngology, endocrinology, neurology, and rehabilitation departments.
To maximize effectiveness of treatment, the Center is divided into cooperating clinics: the Pituitary Gland Tumor Clinic, the Skull Base Tumor Clinic, the Brain Cancer (Malignant Brain Tumor) Clinic, and the Metastatic Brain Tumor Clinic.
Major areas of treatment / Clinics
- Brain tumors (e.g. meningioma and neurilemmoma)
- Malignant brain tumors (glioma)
- Pituitary gland tumors
- Skull base tumors
- Metastatic brain tumors
The Pituitary Gland Tumor Clinic and the Brain Cancer (Malignant Brain Tumor) Clinic
Strong points
1. Achieved the highest number of interventions and operations (as of 2013 based on the number of diagnoses)
- Introduced the Gamma Knife in December 2001 and have performed more than 6,000 treatments by 2013
2. Pioneer personalized medicine that converges clinical practices and research findings.
- Intraoperative navigation systems
- Neuroendoscopic surgery
- Mobile tomography systems
- Brain tumor fluorescent staining
- Intraoperative neurophysiologic monitoring
Diagnostic tests
- Perfusion MRI
- Functional MRI
- Positron emission tomography (PET)
Latest treatment methods
- Intraoperative navigation systems
- Neuro-endoscopic surgery
- Mobile computed tomography (CT)
- Brain tumor fluorescent staining (5-aminolevulinic acid)
- Intraoperative neurophysiologic monitoring
- Intensity-modulated radiotherapy (IMRT), Image-guided radiation therapy (IGRT), and Gamma Knife radiosurgery
Recent trends in clinical research
The Center seeks personalized medicine that combines clinical and research perspectives to treat intractable brain tumors. To provide new treatment opportunities for our patients, we actively engage in key clinical studies on new drugs and procedures and take the lead in developing and applying new treatment early on.